Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Rock2-in-2 | 1995065-79-6 | MFCD31692339 | 98.1% | 360.39 g/mol | C18H12N6OS | 10 MG
SDP

Catalog No. 5000245129
Encompass_Preferred

ROCK2-IN-2 is a selective small-molecule inhibitor of Rho-associated protein kinase 2 (ROCK2) described in patent US20180093978A1 (compound A-30). It is provided for in vitro research use and is reported to have biochemical potency (IC50) below 1 μM. Follow laboratory safety and handling guidance for research reagents.

  • Selective ROCK2 inhibitor.
  • Reported IC50 < 1 μM.
  • Molecular formula: C18H12N6OS.
  • Molecular weight: 360.39 g/mol.
  • CAS number: 1995065-79-6.
  • Purity approximately 98.05% (reported).
  • Soluble in DMSO for stock preparation.
  • Supplied as a 10 mg quantity suitable for assay development.

Catalog No. 50-002-45129 Supplier Medchemexpress LLC Supplier No. HY10362010MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

ROCK2-IN-2 is a selective small-molecule inhibitor of Rho-associated protein kinase 2 (ROCK2) described in patent US20180093978A1 (compound A-30). It is provided for in vitro research use and is reported to have biochemical potency (IC50) below 1 μM. Follow laboratory safety and handling guidance for research reagents.

  • Selective ROCK2 inhibitor.
  • Reported IC50 < 1 μM.
  • Molecular formula: C18H12N6OS.
  • Molecular weight: 360.39 g/mol.
  • CAS number: 1995065-79-6.
  • Purity approximately 98.05% (reported).
  • Soluble in DMSO for stock preparation.
  • Supplied as a 10 mg quantity suitable for assay development.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.